Chemours Earnings Estimate

CC Stock  USD 15.80  0.35  2.17%   
The next projected EPS of Chemours is estimated to be 0.2112 with future projections ranging from a low of 0.15 to a high of 0.36. Chemours' most recent 12-month trailing earnings per share (EPS TTM) is at 0.57. Please be aware that the consensus of earnings estimates for Chemours Co is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
Chemours is projected to generate 0.2112 in earnings per share on the 31st of March 2025. Chemours earnings estimates show analyst consensus about projected Chemours Co EPS (Earning Per Share). It derives the highest and the lowest estimates based on Chemours' historical volatility. Many public companies, such as Chemours, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Chemours Revenue Breakdown by Earning Segment

By analyzing Chemours' earnings estimates, investors can diagnose different trends across Chemours' analyst sentiment over time as well as compare current estimates against different timeframes. At present, Chemours' Operating Profit Margin is projected to slightly decrease based on the last few years of reporting. The current year's Gross Profit Margin is expected to grow to 0.26, whereas Pretax Profit Margin is forecasted to decline to 0.02.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Chemours Earnings Estimation Breakdown

The calculation of Chemours' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Chemours is estimated to be 0.2112 with the future projection ranging from a low of 0.15 to a high of 0.36. Please be aware that this consensus of annual earnings estimates for Chemours Co is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.11
0.15
Lowest
Expected EPS
0.2112
0.36
Highest

Chemours Earnings Projection Consensus

Suppose the current estimates of Chemours' value are higher than the current market price of the Chemours stock. In this case, investors may conclude that Chemours is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Chemours' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
1063.46%
0.11
0.2112
0.57

Chemours Earnings History

Earnings estimate consensus by Chemours analysts from Wall Street is used by the market to judge Chemours' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Chemours' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Chemours Quarterly Gross Profit

273 Million

At present, Chemours' Price Earnings Ratio is projected to decrease significantly based on the last few years of reporting. As of February 25, 2025, Common Stock Shares Outstanding is expected to decline to about 138.6 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 355.7 M.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chemours' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
12.2415.1117.98
Details
Intrinsic
Valuation
LowRealHigh
15.0617.9320.80
Details
Naive
Forecast
LowNextHigh
13.7316.5919.46
Details
9 Analysts
Consensus
LowTargetHigh
22.0424.2226.89
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Chemours assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Chemours. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Chemours' stock price in the short term.

Chemours Earnings per Share Projection vs Actual

Actual Earning per Share of Chemours refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Chemours Co predict the company's earnings will be in the future. The higher the earnings per share of Chemours, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Chemours Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Chemours, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Chemours should always be considered in relation to other companies to make a more educated investment decision.

Chemours Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Chemours' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-26
2024-12-310.15590.11-0.045929 
2024-11-04
2024-09-300.280.40.1242 
2024-08-01
2024-06-300.570.38-0.1933 
2024-04-30
2024-03-310.180.320.1477 
2024-03-27
2023-12-310.250.310.0624 
2023-10-26
2023-09-300.690.63-0.06
2023-07-27
2023-06-301.071.10.03
2023-04-27
2023-03-310.470.980.51108 
2023-02-09
2022-12-310.08-0.6465-0.7265908 
2022-10-25
2022-09-301.041.240.219 
2022-07-28
2022-06-301.431.890.4632 
2022-05-02
2022-03-310.921.460.5458 
2022-02-10
2021-12-310.920.81-0.1111 
2021-11-04
2021-09-301.021.270.2524 
2021-07-29
2021-06-300.941.20.2627 
2021-05-03
2021-03-310.630.710.0812 
2021-02-11
2020-12-310.410.610.248 
2020-11-03
2020-09-300.330.470.1442 
2020-07-30
2020-06-300.10.180.0880 
2020-05-05
2020-03-310.460.710.2554 
2020-02-13
2019-12-310.420.560.1433 
2019-11-04
2019-09-300.590.590.0
2019-08-01
2019-06-300.860.72-0.1416 
2019-05-02
2019-03-310.90.63-0.2730 
2019-02-14
2018-12-310.991.050.06
2018-11-01
2018-09-301.421.490.07
2018-08-02
2018-06-301.591.710.12
2018-05-03
2018-03-311.221.410.1915 
2018-02-14
2017-12-310.971.190.2222 
2017-11-02
2017-09-301.041.120.08
2017-08-02
2017-06-300.850.870.02
2017-05-01
2017-03-310.50.750.2550 
2017-02-15
2016-12-310.290.350.0620 
2016-11-06
2016-09-300.340.610.2779 
2016-08-08
2016-06-300.170.270.158 
2016-05-02
2016-03-310.020.060.04200 
2016-02-23
2015-12-310.080.160.08100 
2015-11-05
2015-09-300.260.19-0.0726 
2015-08-06
2015-06-300.330.24-0.0927 

About Chemours Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Chemours earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Chemours estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Chemours fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings1.7 B1.2 B
Retained Earnings Total Equity2.5 B2.6 B
Earnings Yield 0.03  0.03 
Price Earnings Ratio 29.38  46.57 
Price Earnings To Growth Ratio(0.22)(0.20)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.65)
Dividend Share
1
Earnings Share
0.57
Revenue Per Share
38.677
Quarterly Revenue Growth
(0.01)
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.